Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
J Obstet Gynaecol Res. 2020 Jun;46(6):917-923. doi: 10.1111/jog.14244. Epub 2020 Mar 25.
Endometriosis mostly affects the ovary but can also be present outside of the ovary including the pelvic peritoneum, intestine, urinary tract and lung. In case of ovarian endometriotic cyst, an increased risk of ovarian cancer, especially of clear cell and endometrioid histology, has been reported. However, because of the rarity, cancer occurrence from endometriosis at less common sites/rare sites is poorly understood.
We conducted a nationwide survey on the less common/rare site endometriosis in 3539 authorized facilities in Japan. We requested to complete a case report form for each case, including information on the history of endometriosis, treatment for endometriosis, type of surgery, involved site(s) of cancer and endometriosis, histology of cancer, chemotherapy and outcome.
Out of 1397 confirmed cases of less common/rare site endometriosis, 11 cases of rare site endometriosis-associated cancer (RSEAC) were reported: seven of them were associated with intestinal endometriosis, three were associated with urinary tract endometriosis and one was associated with umbilical endometriosis. Interestingly, the histology was endometrioid in seven (64%) cases, and serous, seromucinous borderline, clear cell and mucinous in one case each (10%), differing from the case of ovarian endometriosis-associated cancer, in which clear cell carcinoma are more common.
Our nationwide survey on RSEAC has revealed that: (i) the incidence of malignant transformation may be lower than ovarian endometriosis, (ii) malignant transformation from endometriosis outside the abdominal cavity may be extremely rare and (iii) the histology of RSEAC is predominantly endometrioid type, suggesting an association of a hormonal effect.
子宫内膜异位症主要影响卵巢,但也可能存在于卵巢外,包括盆腔腹膜、肠、泌尿道和肺。在卵巢子宫内膜异位囊肿的情况下,已报道卵巢癌风险增加,特别是透明细胞和子宫内膜样组织学类型。然而,由于罕见,较少见部位/罕见部位的子宫内膜异位症发生癌症的情况了解甚少。
我们在日本 3539 个授权机构中进行了一项关于较少见/罕见部位子宫内膜异位症的全国性调查。我们要求每个病例填写病例报告表,包括子宫内膜异位症病史、子宫内膜异位症治疗、手术类型、癌症和子宫内膜异位症受累部位、癌症组织学、化疗和结局等信息。
在 1397 例确诊的较少见/罕见部位子宫内膜异位症中,报告了 11 例罕见部位子宫内膜异位症相关癌症(RSEAC):其中 7 例与肠子宫内膜异位症相关,3 例与泌尿道子宫内膜异位症相关,1 例与脐部子宫内膜异位症相关。有趣的是,7 例(64%)的组织学为子宫内膜样型,1 例为浆液性、浆液黏液交界性、透明细胞和黏液型(10%),与卵巢子宫内膜异位症相关癌症不同,其中透明细胞癌更为常见。
我们对 RSEAC 的全国性调查表明:(i)恶性转化的发生率可能低于卵巢子宫内膜异位症,(ii)腹腔外子宫内膜异位症的恶性转化可能极为罕见,(iii)RSEAC 的组织学主要为子宫内膜样型,提示与激素作用有关。